Détails du rapport Vaer
Âge: 60 ans
Genre: Female
Région : Outside US
- Patient décédé?
- Non
- Renseignements sur les vaccins
-
Nom: COVID19 (COVID19 (PFIZER-BIONTECH))
Type : Coronavirus 2019 vaccine
Fabricant: PFIZER
Lot: fe2707
- Date de réception du rapport
- 2022-03-04
- Date à laquelle le formulaire est complèté
- Date de vaccination
- 2021-07-12
- Date d’apparition
- 0
- Nombre de jours (date d’apparition – date de vaccination)
- 0
- Description de l’événement indésirable
-
burning eyes; oculomotor spasm; hairy skin itching; migraine; facial paraesthesia; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority-web. regulatory number: it-minisal02-842718. a 60 year-old female patient (unknown if pregnant) received bnt162b2 (comirnaty), intramuscular, administered in arm left, administration date 12jul2021 (lot number: fe2707) at the age of 60 years as dose 1, single for covid-19 immunisation. relevant medical history included: "primary hyperparathyroidism" (unspecified if ongoing); "migraine" (unspecified if ongoing); "pulmonary nodule under investigation" (unspecified if ongoing), notes: under investigation. the patient's concomitant medications were not reported. the following information was reported: eye irritation (medically significant) with onset 12jul2021, outcome "not recovered", described as "burning eyes"; oculogyric crisis (medically significant) with onset 12jul2021, outcome "not recovered", described as "oculomotor spasm"; pruritus (medically significant) with onset 12jul2021, outcome "not recovered", described as "hairy skin itching"; migraine (medically significant) with onset 12jul2021, outcome "not recovered", described as "migraine"; paraesthesia (medically significant) with onset 12jul2021, outcome "not recovered", described as "facial paraesthesia". the patient underwent the following laboratory tests and procedures: quality of life decreased: (2021) 8/10; specialist consultation: (2021) unknown results. on 14feb2022: the seriousness of the suspected adverse reaction is updated from "serious or permanent invalidity" to "serious-other clinically relevant condition". reporter comment: primary hyperparathyroidism - migraine - pulmonary nodule under investigation - no follow-up attempts are possible. no further information is expected
- Données de laboratoire
-
test date: 2021; test name: impact on quality of life; result unstructured data: test result:8/10; test date: 2021; test name: visit to oculist; result unstructured data: test result:unknown results
- Liste des symptômes
-
paraesthesia pruritus migraine eye irritation quality of life decreased specialist consultation oculogyric crisis
- Patient décédé?
- Non
- Date de décès
- N/A
- Anomalie congénitale
- false
- Vaccin administré par :
- Other
- Vaccin acheté par :
- Inconnu
- Visite d’un patient à l’urgence?
- Non
- Patient hospitalisé?
- Non
- Séjour à l’hôpital
- Non
- Nombre de jours à l’hôpital
- Non spécifié
- Invalidité permanente?
- Non
- Allergies:
-
na
- Maladie actuelle
-
na